You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Recommendations for the Safe Use and Handling of Oral Anti-Cancer Drugs (OACDs) in Community Pharmacy: A Pan-Canadian Consensus Guideline

ID: GL-C50-30 Feb 2017
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
CCO Systemic Treatment, Canadian Association of Provincial Cancer Agencies

Guideline Objective

These recommendations were developed to address the safe handling of oral anti cancer drugs (OACDs) in community pharmacies across the medication lifecycle, from manufacturer packaging to waste management and incident reporting.

Intended Guideline Users